Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication

FDA is committed to continuing to work with states and Indian tribes that seek to develop an importation proposal under section 804 of the Federal Food, Drug and Cosmetic Act.

CGMP/Finished Pharmaceuticals/Adulterated

Unapproved New Drugs/Misbranded

Coronavirus (COVID-19) Update: Daily Roundup

Citalopram (marketed as Celexa) Information

This draft guidance provides information on the implementation of the statutory provision that authorizes FDA to require application holders for certain drug and biological products to make labeling changes based on new safety information that becomes available after approval of the drug.